Trusted by pharmaceutical exporters as a leading FDA U.S. Agent for drug establishment registration, Orionex handles CDER establishment registration, NDC Labeler Code assignment, drug listing, and Drug Master File (DMF) U.S. Agent representation.
📅 Already registered? Drug establishment registration renews annually — see our 2026 renewal guide (Oct 1 – Dec 31, no FDA fee).
What's Included
From NDC assignment through DMF representation, we handle the full CDER registration pathway for pharmaceutical manufacturers.
CDER establishment registration, National Drug Code (NDC) Labeler Code assignment, and U.S. Agent designation for foreign drug manufacturers.
Product listing for each drug product and strength, plus label review against 21 CFR Part 201 labeling requirements.
Drug Master File preparation support and U.S. Agent representation for Type II (drug substance) and other DMF types.
Guidance on cGMP expectations, FDA inspection readiness, and ongoing CDER regulatory correspondence.
Advisory on Over-the-Counter (OTC) monograph compliance for non-prescription drug products entering the U.S. market.
Proactive annual registration renewal reminders and a dedicated account manager for ongoing CDER communications.
Who Needs This
Any foreign establishment that manufactures, prepares, propagates, compounds, or processes a drug product for the U.S. market must register with FDA's Center for Drug Evaluation and Research (CDER) and obtain an NDC Labeler Code.
This applies to prescription drug manufacturers, OTC monograph drug producers, and Active Pharmaceutical Ingredient (API) facilities alike — each foreign establishment must also designate a U.S. Agent to receive FDA communications on its behalf.
Simple Process
Our streamlined process gets your drug establishment registered and compliant fast — without the complexity.
Tell us about your product and market. We assess your needs at no cost.
We provide a clear checklist and guide you through gathering every required document.
We prepare and file directly with FDA. Our CDER-focused team prepares complete submissions to minimize FDA information requests and delays.
You receive your official FDA registration number and Certificate of Registration.
Our Credentials
Orionex is physically incorporated in Casper, Wyoming, with deep regulatory expertise across CDER — from OTC monograph products to DMF-referenced API facilities.
FAQ
Common questions from pharmaceutical manufacturers about FDA CDER registration.
The National Drug Code (NDC) Labeler Code is a unique identifier assigned by FDA to every drug manufacturer, repackager, or distributor. Any foreign establishment registering a drug product for the U.S. market needs one — Orionex handles the application as part of your registration package.
A DMF is a confidential submission providing FDA with detailed information about a drug substance, facility, or manufacturing process — most commonly used by API manufacturers whose material is referenced in another company's drug application. A U.S. Agent is required for DMF holders based outside the U.S.
Orionex charges $550/year for CDER Establishment Registration, NDC Labeler Code assignment, U.S. Agent designation, and an official Certificate of Registration. DMF preparation and label review are available as add-on services.
Yes — both OTC monograph and prescription drug manufacturers must complete CDER establishment registration and drug listing. The distinction matters more for premarket pathway (monograph compliance vs. NDA/ANDA) than for the registration requirement itself.
Through Orionex, drug establishment registration is typically completed in 7–14 business days, reflecting CDER's more detailed review compared to food or device registration. Work begins within 1 business day of order confirmation.
Look for a U.S. Agent with direct CDER experience, physically incorporated in the USA, transparent fixed pricing, and a track record with both finished-drug and DMF-referenced API facilities. Orionex Regulatory Solutions offers all of this, backed by 15+ years of regulatory expertise across CDER.
☀️ Manufacturing sunscreen? Read our sunscreen-specific registration guide — covers OTC Monograph M020, GRASE active ingredients, and the 2026 bemotrizinol approval.
CDER expertise. Transparent pricing. Certificate of Registration included.